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Dysplastic melanocytic nevi (DMN) are distinguished 
his tologically by a hyperplasia of variably atypical in-
traepidermal melanocytes in a lentiginous epidermal 
pattern. In order to further characterize the intraepider-
mal melanocytes of DMN, 4 representative specimens 
each of DMN, acquired nevocellular nevi (NCN), solar 
lentigines (SL), and superficial spreading melanoma 
(SSM) were selected on the basis of predetermined cri-
teria, confirmed in a blind histologic assessment, and 
compared in a quantitative morphologic study using 6 
,.un-thick hematoxylin and eosin stained sections of L-
dihydroxyphenylalanine (dopa) preincubated vertical 
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tissue slices of lesion and adjacent normal skin. The 
average melanocyte frequency, expressed as the percent 
of dopa-reactive perikarya among 600 consecutive basal 
unit cells, was significantly greater in DMN (60 ± 23%) 
than in NCN (18 ± 3%), SL (25 ± 7%), and adjacent skin 
(14 ± 3%), but similar to that in SSM (71 ± 11 %). The 
average mean diameter of 200 consecutive epidermal 
basal unit melanocytes was significantly larger in DMN 
(11 ± 2 I-'m) than in NCN (7 ± 0.4 1-1m), SL (6 ± 0.1 1-1m), 
and adjacent skin (6 ± 0.4 J-tm), but significantly smaller 
than in SSM (16 ± 3 J-tm). The observed similarities of 
intraepidermal melanocytes in selected DMN and SSM, 
as well as distinct differences from melanocytes in se-
lected NCN and SL, support the hypothesis that some 
varieties of DMN may r e present potential precursors of 
cutaneous melanoma. 
Unique varieties of pigmented melanocytic nevi have b en 
distinguished as precursors of cutaneous melanoma [1-11]. 
Such lesions have been recognized in up to 90% of patien ts with 
familial melanoma, and in 42-56% of their nonmelanoma rela-
t ives [1 ,2,4-6]. Identical lesions have been identified in up to a 
third of melanoma patients without a family history of mela-
noma [9,12), compar ed to only 1.8% of 217 aucasian adult 
"controls" without melanoma [12]. The most cha1·acteristic 
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intraepidermal feature of these lesions, designated atypical 
melanocytic hyperplasia [1 ,11] and lentiginous melanocytic dys-
plasia [7], has been identified in up to 22- 33% of melanoma 
specimens from patients without a family history of melanoma 
[3, 7,13]. In several cases, precursor nevi have shown docu-
mented photographic and histologic progression to invasive 
melanoma [1,2]. B-K mole, large atypical nevus (mole) syn-
drome, familial atypical multiple mole-melanoma syndrome, 
and dysplastic nevus are some of the names used to describe 
th ese precw-sor nevi [6]. We prefer the term dysplastic melan-
ocytic nevus (DMN) to help avoid confusion with other types 
of nevi (i.e., vascular, connective tissue) . 
In preliminary histologic investigations using t he L-dihy-
droxyphenylalanine (dopa)-paraffin technique [14], we ob-
served distinguishing morphologic features of intraepiderm al 
melanocytes in acquired pigmented lesions selected on the basis 
of predetermined criteria as DMN, ordinary nevocellular nevi 
(NCN ), solar lentigines (SL), and superficial spreading m ela-
noma (SSM) . In the following studies, we demonstrate t hat 
intraepidermal melanocytes in moderately to markedly atypical 
varieties of DMN are more similar to melanocytes in intraepi-
dermal SSM than to melanocytes in ordinary NCN and SL. 
These observations provide a quantitative morphologic basis 
for the hypothesis that at least some varieties of DMN are 
potential precursors of cutaneous melanoma. 
MATERIALS AND METHODS 
Selection of Lesions 
F ouJ" representative acquired NCN, SL, DMN, a nd SSM (Fig 1-4) 
were se lected by one of the a u thors (A.RR.) for deta iled morphologic 
s tudies. The 16 lesions were diagnosed on the basis of predetermined 
gross a nd microscopic cri teria (Tables 1, II) a nd confirmed in a blind 
histo logic assessment in order to contro l for selection bias (see below). 
The DMN were selected for a moderately to markedly atypical gross 
appearance (Fig 3). The N CN were selected for a " normal" gross 
appearance (Fig 1). The N CN were compound in type [16], predomi-
nantly dermal in one and junctiona l in a nother (Fig lA a nd B, respec-
t ively). 
T he 16 lesions were obtained from 14 white adu lts (8 males and 6 
females) whose ages ranged from 20-74 yem·s (mean 38 yem·s) (Table 
III). Four subjects who donated NCN and/ or SL had had a previous 
SSM (patien ts C. C. and E .K. ) or DMN (patien ts K. C. a nd E.R.) . O nly 
patient K.C. had a family history of mela noma. One NCN, 2 SL, 1 
DMN, and 2 SSM were excised within 2 mon ths of New Engla nd 
summer sun exposure. None of the patients was receiving m·tific ia l 
u ltraviolet radiation or hormona l t herapy. The subjects who donated 
SL ascribed t he appeara nce (and persistence) of their lesions to episodes 
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FI G 1. Four acquired nevoceUula r nevi (A-D) . 
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FIG 2. Four sola1· lentigines (A-D). 
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FIG 3. Four dysplastic melanocytic nevi (A-D). 
of sunburn at least several years before. These studies were conducted 
at t he P igmented Lesion Clinic of Massachusetts General Hospi ta l 
according to consent procedures approved by the Subcommittee for 
Human Stud ies. 
Tissue Preparation. 
Immediately after excision using 1% lidocaine a nesthesia, portions of 
pigmented lesion a nd adjacent norma l skin were processed routinely 
for 4 {'In-thick paraffin sections stained with hematoxylin a nd eosin (H 
& E), a nd according to the dopa-paraffin technique of Laidlaw [141: 
after 5% forma lin fixation at 4 °C for 45 min, l mm-thick vertica l slices 
of fresh t issue were incubated in 3 cha nges of 0.1% DOPA (supplied by 
Hoffmann-La Roche, Inc., Nutley, New Jersey) solu t ion for 24 h, fixed 
in 10% formalin for 24 h, processed routinely fo r paraffin sections, cut 
at 6 {'In thickness, a nd then stained with H & E. 
Assessment of Routine Histologic Sections 
Routine H & E sections were studied in a blind fashion by 2 
dermatopathologists (T. J. H. , M. C. M .) for the presence a nd location 
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of nevus cells, melanocytic hyperplasia and atypism, epidermal hyper-
plasia, lamellar fibrosis, blood vessel proliferation, lymphocytic infil -
t rate, and melan in-laden macrophages. T he grade of melanocytic atyp-
ism (none, s light, moderate, severe, or in traepiderma l melanoma) was 
based on the presence of cellular pleomorphism, mitoses, nuclear hy-
perchromasia, coarse granular chromatin pattern, irregular nuclear 
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FIG 4. Four superficia l spreading melanomas (A-D). 
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borders, and nucleolar prominence [9,20]. Melanocyte fr equency was 
graded as "no increase" when similar to normal skin, "slight ly in-
creased" when similar to an ordinary lent igo [16,19], " moderately 
increased" when melanocytes equaled the number of basal keratino-
cytes, or "markedly increased" when melanocytes obscmed and ex-
tended just above the basal keratinocytes [7,9]. 
Atypical melanocytic hyperplasia was defined as a discontinuous 
proliferation of variably atypical melanocytes in or s ligh tly above the 
epidermal basal unit [1,7,11]. Intraepidermal SSM was judged to be 
present when severely atypical melanocytes spanned the breath of the 
epidermis focally or diffusely [9,20]. The melanocyte type was desig-
nated predominantly "spindle" if t he majority of cells were elongate, 
"epithelioid" if most cells were round or oval with abundant pink 
cytoplasm, or " mixed" if approximately equal numbers of each type 
were present [7,9]. 
Assessment of Dopa-Incubated Sections 
Melanocyte frequency, determined by coun t ing 600 consecutive basal 
uni t ce lls, was expressed as the percent of dopa-reactive melanocytes. 
Melanocyte size was estimated with an ocula1· micrometer (1.25 p.m/ 
division at 400X) by measuring the greatest diameter of 200 consecutive 
basal uni t dopa-reactive perika1·ya. Perikarya smaller than 3.75 J.Ll11 
were excluded in order to avoid counting dendrites. Frequency and size 
assessments were made at 400X magnification, excluding ha ir follicles 
and overlapping cells. When multiple t issue sections were used, double 
assessment of the same melanocyte was avoided by skipping at least 
every other tissue section. For SSM, melanocytes were examined in th e 
in traepidermal component adjacent to invasive tumor. Melanocytes in 
adjacent normal skin were assessed > 2 rete ridges away from the 
int raepidermal and dermal components of the lesion. 
Statistical Analysis 
All compai"isons were made using t he one-sided F isher's randomiza-
tion test [21]. 
RESULTS 
Clinical Characteristics (Table III, Figs 1-4) 
The 16 lesions were located predominantly on the torso. 
Differences in selection criteria for the 4 categories resulted in 
average differences in gross lesion size and color. The average 
TABLE I. Four categories of acquired pigmented lesions: gross selection criteria" 
Category 
Nevocellulru· nevi 
Solar lentigines" 
Dysplastic melanocytic 
nevi 
Superficia l spreading mel-
a noma 
Pattern of co loration'' 
Shades of ligh t to medium brown, ± 
flecks of dark brown clistribu ted 
evenly 
Shades of ligh t brown d istributed 
evenly 
Shades of ligh t, medium, and dark 
brown (± red) distributed haphaz-
ardly, or dru·kly pigmented 
Shades of light, medium, and dark 
brown (± red) and/or black and blue-
gray, distributed haphazardly 
Border 
Regular (oval or round) 
Well-demarcated 
Hegulru· or iJTegular 
Inegul ru· and/or poorly de-
mru·cated 
Irregular and/or poorly de-
marcated 
Surface'· 
Distortion 
S kin markings normal or accen-
tuated evenly 
No distortion (maculru·) 
S kin markings normal 
D istortion 
Skin mru·kings disrupted at least 
in prut 
Distortion 
Skin markings disrupted almost 
tota lly 
"All lesions ;;;. 4 mm in size to facilitate multiple histologic studies. 
1
' Immersion oil app lied to smface, lOX hand lens magnification [15]. 
c As judged by tangential ligh ting and lOx hand lens magnification. 
"Selected for a site of previous sun exposure (i.e., upper back). 
Category 
NevoceUulru· nevi 
Solar lentigines 
Dysplastic melanocytic 
nevi 
Superficial spreading mel-
anoma 
TABLE II. Four categories of acquired pigmented lesions: histologic selection criteria 
Histology 
Nevus cells in epidermis (well-disposed nests) and /or dennis 
Increased numbers of normal melanocyies concentrated a long club-shaped epidermal rete 
Len tiginous proliferation of variably atypical melanocytes in or sligh tly above the epider-
mal basal unit plus one or more de rmal features: nevus cells," increased blood vessels, 
increased lymphocytes, fibrosis along epidermal rete, prominent melanin-laden macro-
phages 
Proliferation of severely atypical melanocytes spanning the epidermis and penetrating at 
least in to the papillary dermis 
"Dermal nevus cells not an abso lute requirement for the diagnosis of dysplastic melanocytic nevus [1, 8, 11]. 
R efe rences 
[16-17] 
[16-19] 
[1-ll] 
[9, 16, 17, 20] 
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mean gross size of DMN (12 ± 4 mm) (mean ± SD) was larger 
than that of SL (7 ± 2 mm) and NCN (5 ± l mm) (p < 0.03, 
both comparisons), but less than that of SSM (20 ± 14 mrn) (p 
< 0.05) . The average mean number of colors of DMN (4 ± 0.6) 
was greater than that of NCN (2 ± 0.5) and SL (1 ± 0) (p < 
0.02, all comparisons), but fewer than that of SSM (6 ± 1) (p 
< 0.02) . In general, DMN were more darkly pigmented than SL 
and NCN (p < 0.03, both comparisons), but not as darkly 
pigmented as SSM (p < 0.02) . 
Blind Assessment of Routine Histologic Sections (Table IV) 
The degree ofmelanocytic atypia in DMN (Fig 5) was judged 
to be less than that in SSM (Fig 6). Melanocytic a typia was not 
present in NCN and SL. The degree of melanocytic hyperplasia 
in DMN (Fig 5) was similar to that in SSM (Fig 6), but greater 
than that in SL and NCN. In DMN, the cell type was predom-
inantly epithelioid in 1 and mixed in 3. In SSM, it was epithe-
lioid in 3 and mixed in l. A dermal nevus was present in all 4 
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NCN, 2 DMN, and 2 SSM. Epidermal hyperplasia was present 
in all16 lesions (moderate or marked in 2 NCN, 1 SL, 3 DMN, 
and 3 SSM) . 
Assessment of Dopa-Incubated Sections 
The intraepidermal component of SSM contained large, 
crowded, intensely dopa-reactive, markedly dendritic or globu-
laT melanocytes diffusely permeating the epidermis (Figm e 
7A). A discontinuous array of densely disposed, large, strongly 
dopa-reactive and dendritic melanocytes was also apparent in 
DMN, often distTibuted in irregular or ellipsoidal "nests" bridg-
ing adjacent epidermal rete (Fig 7B,C). Well-defined theques 
of junctional nevus cells [16] were not present in the DMN. 
Large melanocytes in DMN were confined to the basal unit or 
slightly above, and were only rarely as large as t hose in SSM. 
Melanocytes in NCN and SL (Fig 7D,E) were similru· in size to 
melanocytes in adjacent normal skin (Fig 7F). Basal unit mel-
anocytes between epidermal nests of nevus cells in NCN (Fig 
TABLE Ill. Clinical characteristics of 16 acquired pigm.ented lesions in 4 clinical categories 
Category 
Nevocellular nevi 
Solar lentigines 
Dysplastic mela nocytic 
nevi 
Superficial spreading 
melanoma 
Lesion" 
1A 
1B 
1C 
lD 
2A 
2B 
2C 
2D 
3A 
3B 
3C 
3D 
4A 
4B 
4C 
4D 
Subject (age/sex/Skin Type") 
K C." (22/M/II) 
C.C. (25/ F / III) 
S .M .'' (24/M/ III) 
E.R. (20/F/- ) 
S.M." (24/M / III) 
M .M. (24/ F /II) 
E.K. (40/ M/ II) 
M .R. (20/ M / Ill) 
KC." (22/ M / 11) 
B.H. (56/F / III) 
J .L. (52/M/Il) 
R.S. (39/M/II) 
H.K. (53/M / III ) 
J .D. (35/ F / II) 
E.R. (74 / M / III) 
D.C. (55/ F / Il 
T, tan; B, brown; DB, da rk brown; Bk, black; Bl, blue; P , pink; G, gray. 
" Corresponds to figure legend of gross lesion in text (Figs 1-4). 
Site 
Back 
Chest 
B ack 
Back 
Back 
B ack 
Back 
Back 
Back 
Chest 
Back 
Chest 
T high 
Back 
Back 
Cheek 
Size, mm Surface I ' Color 
6x 4 ++ T 
5 x 3 + B , DB 
4x4 + T , B 
6x5 ++ T ,B 
6x5 0 T 
5x3 0 T 
7x4 0 T 
10 X 5 0 T 
8x7 + T , B , DB 
15 X 10 + T , B, DB, P 
9x7 + T , B, DB 
17 X 12 + T, B, DB, P 
12 X 11 ++ T , B , DB, B k, B\ 
38 X 20 ++ T, B , DB, Bk, Bl, P 
15 X 12 ++ T , B, DB, Bk, Bl, G, P 
13 X 11 ++ T , B, DB, Bk, Bl, G, P 
b Skin T ype for Caucasians according to init ia l and repeated 30-45 min of noon early summer sun exposure in New E ngland . 1: a lways burns, 
never tans. II: a lways burns, tans slightly. III: usua lly burns with fi1·st few exposures, tans welL IV: never burns, tans well. 
c Surface distortion none (0) , slight (+), or obvious (++) according to tangentia l lighting. 
" K.C. and S.M. donated 2 lesions each. 
TABLE IV. Blind histologic assessment of 16 a.cqu.ired pigmented lesions in 4 clinical categories 
Epidermal melanocytes 
Category Lesion" Dermal Nevus Hyperplasia Atypism 
Nevocellu lar nevi lA yes + 0 
l B yes 0 0 
lC yes + 0 
lD yes + 0 
Solar lentigines 2A no + 0 
2B no + 0 
2C no + 0 
2D no + 0 
Dysplastic melanocytic nevi 3A no +++ +++ 
3B no +++ ++ 
3C yes +++ +++ 
3D yes +++ ++ 
Superficial spreadjng mela- 4A yes +++ SSM(II/ 0.35)' 
noma 4B no +++ SSM(III/ 0.9) 
4C yes +++ SSM(III/ 0.5) 
4D no +++ SSM(IV/ 1.0) 
BV, blood vessels, Inflamm, inflammation; 0, none;+, sligh t;++, moderate; +++, mrn·ked. 
"Conesponds to figure legend of gross lesion in text (Figs 1-4). 
b Lowest magnification melan in-laden macrophages visualized. 
Fibrosis 
+ + 
+ 
0 
+ 
0 
0 
+ 
0 
++ 
+ 
++ 
++ 
++ 
+++ 
++ 
++ 
c SSM, superficial spreading melanoma (anatomic level of invasion/tumor thickness in mm). 
Dermal mesenchymal changes 
Increased BV Inflamm 
0 0 
0 0 
0 + 
+ 0 
0 0 
0 0 
0 + 
0 + 
++ ++ 
++ + 
++ ++ 
++ ++ 
++ ++ 
+++ + 
++ ++ 
+ + ++ 
Melano· 
phages'' 
400x 
lOOX 
200X 
lOOx 
400X 
400X 
lOOx 
IOOX 
40X 
lOOx 
40X 
lOOX 
40X 
40X 
40X 
40x 
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FI G 5. Dysplastic melanocytic nevi (A,B) (histology of lesions 
shown in Fig 3C and 3D, respectively). In both A and B, a lentiginous 
hyperplasia of variably atypical melanocytes as single cells or irregular 
nests is confmed to the basal unit or slightly above, and lamellar 
fibroplasia and lymphocytic inflltrate are noted in the dermis. In A , 
melanin-laden macrophages are prominent. In B, spindled melanocytes 
form irregula r ellipsoidal nes ts which bridge rete ridges (center) . H & 
E, X 256. 
7D) were normal in number or increased slightly, but not as 
prominently increased as in DMN (Fig 7B,C) or SSM (Fig 7A). 
Melanocytes in normal skin adjacent to the 16 lesions were not 
consistently different in size or frequency when any one lesion 
category was compared with another. 
Quantitative Assessment in Dopa H & E Sections (Table V) 
The average frequency of intraepidermal dopa-reactive mel-
anocytes was greater in DMN (60 ± 23%) than in SL (25 ± 7%), 
NCN (18 ± 3%), and adjacent normal skin (14 ± 3%) (p < 0.02, 
all comparisons), but not different from SSM (71 ± 11%) (p > 
0.2). 
The average mean diameter of dopa-reactive melanocytes in 
the epidermal basal unit of DMN (11 ± 2 !J.m) was larger than 
that in NCN (7 ± 0.4 !J.m), SL (6 ± 0.1 f.!m), and adjacent normal 
skin (6 ± 0.4 f.!m) ( p < 0.02, all comparisons), but smaller than 
that in SSM (16 ±311m) (p < 0.03) . Differences were also noted 
among the 4 lesion categories for the percent of abnormally 
large melanocytes. The average percent of melanocytes :::: 1.5 
times larger than the average mean diameter of melanocytes in 
adjacent normal skin was greater in DMN (51 ± 20%) than in 
NCN (7 ± 3%), SL (2 ± 0.6%), and adjacent normal skin (2 ± 
2%) (p < 0.02, all comparisons), but less than in SSM (83 ± 
11%) (p < 0.03). The average percent of melancoytes 2: 2.5 
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FIG 6. Superficial spreading melanoma (histology of lesion shown in 
Fig 4A ). Severely atypical epithelioid melanocytes span the epidermis 
as single cells and _small nests. H & E, X 256. 
times larger than melanocytes in adjacent normal skin was 
greater in SSM (44 ± 14%) than in DMN (11 ± 9%) (p < 0.03) . 
Melanocytes in normal skin adjacent to the 16 lesions re-
vealed no consistent quantitative differences in frequency or 
size from one lesion category to another. 
DISCUSSION 
This study demonstrates the usefulness of the dopa-paraffin 
technique for quantifying morphologic differences of intraepi-
dermal melanocytes among 4 highly selected categories of pig-
mented lesions. We observed that intraepidermal melanocytes 
in moderately to markedly atypical varieties of DMN and 
intraepidermal SSM were more similar to each other in size 
and frequency than to melanocytes in "normal" varieties of 
NCN and SL. The size and disposition of intraepidermal dopa-
reactive melanocytes also helped to differentiate DMN from 
intraepidermal SSM. The presence of severely atypical, gigantic 
melanocytes at all levels of the epidermis was unique to SSM 
(Fig 7A), as previously demonstrated in frozen sections using 
formalin-induced fluorescence [22]. In contrast, variably atypi-
cal melanocytes confined to the basal epidermal unit or only 
slightly above characterized DMN (Fig 7B,C). Small melano-
cytes were more apparent in NCN and SL (Fig 7 D,E) than in 
DMN (Fig 7B,C) and SSM (Fig 7A). Therefore, our exclusion 
of dopa-reactive perikarya smaller than 3.75 f.!m (to avoid 
counting dendrites) adds strength to the observed quantitative 
differences among the 4 lesion categories (Table V). 
Our observations in selected examples ofDMN are consistent 
with previous studies of melanocytic dysplasias in patients with 
and without a personal or family history of melanoma [1,4,6-
8,10,11]. However, not all DMN are histologically (or grossly) 
as atypical as the 4 lesions we selected for quantitative studies. 
In unpublished investigations, histologic changes in 116 DMN 
defined by predetermined gross criteria (and studied by the 
dopa-paraffin technique in 25% of cases) included at least slight 
melanocytic hyperplasia; the degree of melanocytic atypism 
usually corresponded to the degree of gross atypism (A.R .R., 
unpublished observations). In 228lesions characterized by atyp-
ical melanocytic hyperplasia reported by Sagebiel [11], a range 
of melanocytic atypia was also noted, but gross correlations 
were not provided. Clark, Reimer, Greene et al [1] observed 
that multiple sections were often required to detect melanocytic 
atypia in atypical nevi from kindreds with familial melanoma. 
Dermal nevocellular nevi are a variable feature of DMN, 
regardless of whether patients have a personal or family history 
of melanoma [1,8]. Sagebiel noted the absence of dermal NCN 
in half of 228 lesions characterized by the presence of atypical 
melanocytic hyperplasia [11]. Clark et al reported the absence 
of dermal NCN in some atypical nevi from patients with familial 
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FIG 7. Comparison of dopa-reactive melanocytes ( a /Tows) in four categories of acquired pigmented lesions and adjacent normal skin (A -F). 
A , S uperficial spreading melanoma (see Fig 4B ). Band C, Dysplastic melanocytic nevi (see Fig 3C a nd 3D , respectively). D, Nevocellula r nevus 
(See Fig l C ). E , Solar lentigo (see Fig 2A ). F, Normal skin adjacent to superficia l spreading melanoma (see F ig 4C). See text for descriptions. 
Dop a H & E , 6 I-'m-thick section, X 400. Scale line 10 J.Lm . 
mela noma and their nonmelanoma blood rela tives [1]. Of 116 
DMN obtained from 57 patients (24 of whom had melanoma 
and 2 others a family history of melanoma), 13.8% of the lesions 
had no evidence of dermal nevus cells, despite the a vaila bili ty 
of serial sections (A.R.R., unpublished observations). Two of 
the 4 DMN we selected for quantitat ive morphologic studies 
had no dermal nevus cells (Table IV) . 
Gross, ligh t microscopic, and ul trastructm·al comparisons of 
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TABLE V. Intraepidermal dopa-reactive melan.ocytes in lesional and adjacent normal shin of 16 acquired pigmented lesions in 4 clinical 
categories 
Frequency, %1' Size,J.Lmc Large Melanocytes, %'1 
Category Lesion" 2: I.SX 2: 2.5X 
Lesion ANS Lesion ANS 
Lesion ANS Lesion ANS 
Nevocellular nevi lA 22 20 8±2 7±2 8 4 0 0 
1B 15 13 7±2 6 ± 1 4 1 0 0 
1C 18 16 7±2 6±1 6 0.5 0.5 0 
lD 16 10 7±2 6±1 10 2 0.5 0 
Solar lentigines 2A 27 11 6±2 6±1 2 2 0 0 
2B 15 9 6±2 6±1 2 2 0 0 
2C 28 15 6 ± 1 6±1 1 1 0 0 
2D 28 13 7 ± 1 7±2 2 2 0 0 
Dysplaslit: melanocytic nevi 3A 38 16 14 ± 5 7±2 76 6 24 0 
3B 92 16 11 ± 3 7 ± 1 58 1 6 0 
3C 53 17 9±3 6±2 31 3 4 0 
3D 59 14 11 ± 3 7 ± 1 38 2 10 0 
Superficial spreading mela- 4A 70 15 19 ± 7 6 ± 1 92 0 54 0 
noma 4B 72 14 17 ± 5 7±2 89 2 44 0 
4C 59 15 13 ± 6 6±2 63 0.5 23 0 
4D 84 14 18 ± 6 7±1 87 2 54 0 
ANS, adjacent normal skin. 
"Corresponds to figure legend of gross lesion in text (Fig 1-4). 
"The proportion of melanocytes among 600 consecutive cells (melanocytes and keratinocytes) in the epidermal basal unit, x 100%. 
' Mean ± SD, estimated from measurements of n = 200 consecutive intraepidennal melanocytes, except for adjacent normal skin of lesions lB 
(n = 191) and 4A (n = 130). 
" Defined as the proportion of melanocytes 2: 1.5 times and 2: 2.5 times larger than the mean melanocyte size in 16 specimens of adjacent 
normal skin, x 100%. 
malignant and benign melanocytic tumors have been conducted 
using a variety of methods. The "overlap" in diagnostic features 
that is usually noted could be due to the failure of recognizing 
DMN as a distinct entity. Visualization of the pigment pattern 
appeared to be useful for predicting melanoma in the preoper-
ative assessment of cutaneous melanocytic lesions [15]; how-
ever, some "benign" lesions were mistaken for melanoma. Using 
routine histologic sections, "control" nevi from a pathology file 
were compared to nevi from patients with melanoma [10]; many 
of the "control" nevi had histologic features similar to DMN. 
ElectTOn microscopy was used in an attempt to differentiate 
"benign melanoma simulants" from intraepidermal melanoma 
[23]; intraepidermal melanocytes in the simulants were fre-
quently similar to intraepiderma1 melanocytes in SSM. We 
think it likely that at least some benign "melanoma simulants" 
and nevi selected from pathology files will include DMN. When 
DMN are studied ultrastructurally, individual epidermal mel-
anocytes may be indistinguishable from those in intraepidermal 
SSM [24]. Future diagnostic studies of pigmented lesions may 
benefit from distinguishing DMN from NCN, SL, and intrae-
pidermal SSM using predetermined gross and microscopic cri-
teria. 
Routine histologic sections have been used to estimate the 
frequency of intraepidermal melanocytes in NCN and mela-
noma [25]. However, we find routine sections to be unreliable 
for accw·ate frequency and size assessments. Dopa-incubated 
epidermal sheets have also been used to study pigmented 
lesions. Our own observations using this technique for NCN, 
SL, and SSM are qualitatively similar to published reports 
[19,26]. However, we· find that an accw·ate assessment of me-
lanocyte size and density using dopa-incubated epidermal 
sheets is virtually impossible for -pigmented lesions; melano-
cytes are frequently concentrated about elongated epidermal 
rete in multiple planes of microscopic focus, obscw·ed by exces-
sive melanin in surrounding keratinocytes. In contrast, dopa H 
& E sections permit the visualization of individually disposed 
intraepidermal melanocytes in relationship to keratinocytes in 
a single plane of focus, providing a quantitative basis of com-
parison among different categories of pigmented lesions (Fig 
7A-E). 
Although we selected our DMN for relatively large size and 
skin surface distortion, we would not exclude the diagnosis of 
DMN (or melanoma) on the basis of gross size or sw-face 
characteristics. We are aware of histologically dysplastic and 
malignant melanocytic tumors that are small, i.e., < 5mm. 
Grossly atypical lesions that distort the skin surface little or not 
at ali include varieties of melanocytic dysplasias arising on sun-
damaged skin (i .e., lentigo maligna) [9,17,20], acral surfaces [27-
29], and mucous membranes [29,30]). Border contow- by itself 
is also not helpful for predicting melanocytic dysplasia, i.e., SL 
usually have irregular borders (Fig 2), while some melanoma 
have borders that are only minimally irregulal" (Fig 4B). We 
are unaware of gross features that accurately predict the ab-
sence of melanocytic dysplasia in pigmented lesions masquer-
ading grossly as DMN or melanoma. 
Our comparative morphologic studies support the contention 
that some recognizable varieties of melanocytic dysplasia 
should be regru·ded as potential melanoma precursors [1-11, 
13,17,20,24,27-30]. These lesions are usually chru·acterized 
grossly by haphazard or very dark coloration, and microscopi-
cally by patterns of atypical melanocytic hyperplasia. The 
lentiginous proliferation of variably atypical melanocytes in 
DMN may represent potential foci for progression to neoplasia, 
as postulated for other malignancies in which grossly and 
microscopically identifiable atypical hyperplasias may play a 
significant role [31]. This concept, when applied to melanoma, 
emphasizes the recognition of potential precursors in a preme-
tastatic phase of growth. 
Dr." George Szabo generously provided advice and encoUTagement, 
Mr. William Farinelli assisted in the prepmation of dopa-sections, and 
Ms. Sandra Lania prepared the manuscript. 
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Localization of Melanoma-Associated Antigen p97 in Cultured Human 
Melanoma, as Visualized by Light and Electron Microscopy* 
WOLFGANG TILGEN, M.D., lNGEGERD HELLSTROM, M.D. , MONIKA ENGSTNER, H. JACQUES GARRIGUES, 
RUDIGER RIEHL, PH.D., AND KARL ERIK HELLSTROM, M.D. 
Uniuersitiits-Hautldinih (WT, ME, RR), Heidelberg, F.R .G., and Fred Hutchinson Cancer Research Center (IH, HJG, KEH), Seattle, 
Washington, U.S.A. 
The expression of a human melanoma-associate d an-
tigen, p97, in cultured melanoma cells was investigated 
using a modification of the Sternberger p e roxidase -an-
tiperoxidase (PAP) technique. Explant cultures of two 
skin melanomas were found to consist of a mixture of 
cells, some positive and some negative, for the expres-
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Abbreviations: 
MEM: minimal essential medium 
PAP: peroxidase-antiperoxidase 
PBS: phosphate-buffered saline 
sion of p97. From two other melanomas two cell lines 
were newly established. All cells from these lines ex-
pressed d etectable p97 over a period up to 18 months. 
With the cell lines and the explant cultures we have 
initiated an investigation of the expression of p97 at t h e 
ultrastructural leve l, using the PAP technique. Antigen 
expression was d etected as a continuous, strongly 
staine d band at the cell s urface of the melanoma cells. 
Monoclonal antibodies to various tumor-associated cell sur-
face a ntigens of human m elanoma h ave been obtained [l-12]. 
One of these a ntigen s is p97, a glycoprotein of M ,.- 97,000 
[3,4,13]; the same antigen h as been called gp95 by Dippold et 
al [6]. Studies performed with immunoprecipitation [3,13), ab-
sorption [6], and binding techniques [ 4,13,14] have shown that 
p97 is strongly expr essed (50,000-400,000 molecules/ cell ) by 
abou t 50% of melanomas and more weakly (10,000-50,000 mol-
